840
Comments (73)
sorted by:
You're viewing a single comment thread. View all comments, or full comment thread.
-4
lo_there -4 points ago +3 / -7

"This is a hypothetical scenario designed to illustrate the public health risk communication challenges that could potentially emerge during a naturally occurring infectious disease outbreak requiring development and distribution of novel and/or investigational drugs, vaccines, therapeutics, or other medical countermeasures. The infectious pathogen, medical countermeasures, characters, news media excerpts, social media posts, and government agency responses described herein are entirely fictional."

What exactly are we supposed to be getting mad about? This is a literal LARP scenario. Completely fictional; a brain exercise to predict what may happen in the future.

9
Trumpenproletariat 9 points ago +9 / -0

"You are saying They planned the Global Totalitarian Coup before executing the Global Totalitarian Coup? ... nah, it's just a LARP, bro."

-3
lo_there -3 points ago +1 / -4

Who is "they" the author of the work of fiction? You are the one making the claim it's a mirror image to our current experience. List one identical part of the text to what has happened.

4
BeetlejuiceForSenate 4 points ago +4 / -0

Countries recall or refuse certain vaccines:

In September 2026, two months after the first batches of Corovax were released in the United States, Japan announced that it would not approve the vaccine for use in Japan due to concerns that it had not been vetted properly through full clinical trials. Preliminary Corovax trials conducted in Japan had shown that the vaccine was effective at preventing SPARS and that the incidence of immediate side effects was minimal; however, significant concerns remained about the possibility of chronic, long-term side effects based on data from the original GMI vaccine. As an alternative, the Japanese government stated that it would continue the development of an alternative SPARS vaccine, which they expected to become available in early 2027.

Japan’s refusal to accept Corovax was widely covered in the international media. The decision was particularly controversial because of widespread SPARS transmission across Japan. The fact that the Japanese government was willing to wait six or more months for another vaccine to be developed was also especially concerning to the US public. Compounding this concern was the general lack of a response to the Japanese decision from the US government. Although HHS Secretary Nagel released a short statement reiterating the safety of Corovax, the CDC, FDA, and other government agencies did not respond at all, a reflection of a longstanding tradition of not commenting on other countries’ internal public health decisions. From the public’s viewpoint, however, the lack of a response from trusted government agencies only exacerbated vaccine fears.